← Evidence map

ArticleNature medicine2019

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients.

Ryan J Sullivan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

141 papers cite itlatest 60 shown

2019
…
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31171876